Bio Innovation

PhD in Genetics

He has presided over and participated in the completion of a number of national 973 projects and national research programs of NSFC, and has published 71 papers in the international famous academic journals Nature Communications, Stem Cell,JBC, of which 41 are included in SCI(Science Citation Index). At present, he is engaged in the clinical application of dental stem cells, the mechanism of abnormal tooth development and related diseases, and the research and development of oral care products.

PhD in Molecular Biology

He has been engaged in the research and development of new biological and cellular drugs for more than 20 years, and is well versed in the industrialization of stem cells and immune cells. He has rich experience in the development of new cellular drugs(stem cells and immune cells) and the industrialization of clinical applications, and has presided over and participated in a number of cellular drug filing and clinical research projects.

He has been deeply engaged in the health and wellness field for more than 10 years, and has summarized a unique comprehensive program and a wide range of successful cases in the research and development of stem cells and their derivative products and their application in anti-aging health care, cancer prevention and other fields. He has a number of domestic and international patents.

PhD in Molecular Biology

He has been engaged in the theoretical research and technical application of human genomics and phenomics for many years. He is responsible for the construction of several expression profilling chip technology platforms and the research and development of tumor early screening chips and diagnostic chips. He has developed colorectal cancer diagnostic chips, non-small cell lung cancer diagnostic chips, and screening for multiple tumor drug targets. At the same time, he is deeply engaged in the research and develop.ment of stem cells, immune cells, and their derivative products, especially in the preparation and industrialization of immune cell exosome products.

Li Zhu | PhD

With years of focus on the research and development of glycoengineered cellular drugs, Dr. Li has published 16 papers in prestigious journals including 'ACS Central Science', 'Chemical Science', and 'Biosensors and Bioelectronics', obtained 20 authorized patents, including 2 US patents.

Dr. Li co-founded AXOSOME, a biotech startup focusing on exosome-based drug development, which was later acquired for tens of millions of dollars.

• Associate Professor at Peking University Ningbo Marine Drug Research Institute
• Visiting Professor at Third Institute of Oceanography, Ministry of Natural Resources
• Academic Committee Member of Xiamen Cell Therapy Research Center

Liu Yugang | PhD

Graduated from Shenyang Pharmaceutical University, with over 20 years of deep expertise in vaccine production, cell therapy, and exosome research, specializing in the R&D of production processes for stem cell-derived exosome drugs.

Successfully developed mature industrial production processes including exosome production, concentration, purification, and lyophilization.

TCM GAO

Graduated from the Clinical Department of Traditional Chinese Medicine of Shanxi University of Chinese Medicine, a member of the Communist Party of China, an associate chief physician of traditional Chinese medicine Internal medicine, a member of the Chinese Medical Association, and a member of the Jiangsu Acupuncture and Moxibustion Society, with 20 years of experience in traditional Chinese medicine internal medicine and acupuncture and massage clinical practice. Has worked in top-tier hospitals in Beijing, Shanghai and other places, and has rich clinical experience! More than 10 academic papers at the provincial and municipal levels have been published! Combining the ideas of predecessors, it has carried forward the "internal disease external treatment, internal and external integration" medicinal needle therapy, forming a certain medical system and achieving remarkable therapeutic effects!